Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down After Analyst Downgrade
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report)’s share price gapped down before the market opened on Thursday after The Goldman Sachs Group lowered their price target on the stock from $28.00 to $24.00. The stock had previously closed at $10.63, but opened at $10.15. The Goldman Sachs Group currently has a buy rating on […]
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report)’s share price gapped down before the market opened on Thursday after The Goldman Sachs Group lowered their price target on the stock from $28.00 to $24.00. The stock had previously closed at $10.63, but opened at $10.15. The Goldman Sachs Group currently has a buy rating on […]
